Biological attributes required for epidermal regeneration: Evaluation of the next‐generation autologous cell harvesting device

Abstract Early wound intervention and closure is critical for reducing infection and improving aesthetic and functional outcomes for patients with acute burn wounds and nonthermal full‐thickness skin defects. Treatment of partial‐thickness burns or full‐thickness injuries with autologous skin cell suspension (ASCS) achieves robust wound closure while limiting the amount of donor skin compared with standard autografting. A Next Generation Autologous Cell Harvesting Device (NG‐ACHD) was developed to standardize the preparation process for ASCS to ensure biological attributes are obtained known to correlate with well‐established safety and performance data. This study compared ASCS prepared using the NG‐ACHD and ACHD following the manufacturer's guidance, evaluating cellular yields, viability, apoptotic activity, aggregates, phenotypes and functional capacity. Non‐inferiority was established for all biological attributes tested and comparable healing trajectories were demonstrated using an in vitro skin regeneration model. In addition to standardization, the NG‐ACHD also provides workflow efficiencies with the potential to decrease training requirements and increase the ease of incorporation and utilization of ASCS in clinical practice.